BIG LAKE, MINN. (February 23, 2021) – Bionote USA, manufacturer of point-of-care veterinary analyzers and biomarker tests, welcomes Jerry Scott as its new National Sales Manager – Eastern U.S. Scott is responsible for representing Bionote’s Vcheck line of quantitative analyzers and tests with Bionote distribution partners and through direct sales in the Eastern U.S.
With nearly two decades of experience in the medical and animal health industries, Scott will utilize his expertise to work with distribution, veterinary practice owners and staff to ensure customer satisfaction as well as maintain an instrumental role in product installations and training. He is also tasked with educating veterinary practices in the region about the recently launched NT-proBNP test, the first and only in-clinic, quantitative diagnostic test kit for the early detection of heart disease in dogs.
“Jerry is a great addition to our team. Our distributors and veterinary professionals in the Eastern U.S. can really depend on his follow-through and significant industry background to get them dialed in to the best point-of-care solutions from Bionote,” said Randy Knick, senior vice president of operations and sales, Bionote USA.
All Vcheck tests, and both the Vcheck V200 and V2400 analyzers, for small and large veterinary clinics respectively, can be used as a complement to your point-of-care lab for time-saving diagnosis, along with significant cost savings per test.
Bionote’s line of quantitative diagnostic products are currently available in the U.S. and Canada. To learn more about Bionote USA and the Vcheck line of analyzers and tests or to place an order, contact Jerry Scott at jerryscott@bionote.com. The company can also be contacted directly through its website: www.bionote.com.